State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 108 actively recruiting studies with Kansas sites out of 108 registered in total. The busiest research areas in Kansas are Head and Neck Cancer, Prostate Cancer, Heart Failure. Leading sponsors running trials in the state include University of Kansas Medical Center, National Cancer Institute (NCI), Incyte Corporation. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (33), Phase 3 (33), Phase 4 (3).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 108 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 108. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Head and Neck Cancer, Prostate Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT06879340 Phase 1
Recruiting
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With ...
Condition
B-Cell Non-Hodgkin Lymphoma
Enrollment
54 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06460116 N/A
Recruiting
Health Equity and Rural Education (HERE!) Clinical Trial
Condition
Behavioral Symptoms
Enrollment
126 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04864054 Phase 1, Phase 2
Recruiting
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
60 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT07796178 Phase 4
Recruiting
Evaluation of Lacrifill
Condition
Dry Eye
Enrollment
40 pts
Location
United States
Sponsor
Eye Research Associates, LLC
NCT06123182 N/A
Recruiting
Guided Episodic Future Thinking to Increase Physical Activity Adherence and Prom...
Condition
Exercise Training
Enrollment
160 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06858189 Phase 2
Recruiting
Promoting Active Therapy: Path to Wellness
Condition
Depression, Anxiety
Enrollment
60 pts
Location
United States
Sponsor
Kansas State University
NCT06765668 Phase 4
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Partici...
Condition
Parkinson Disease
Enrollment
220 pts
Location
United States
Sponsor
Impax Laboratories, LLC
NCT06976268 Phase 2, Phase 3
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment...
Condition
Parkinson Disease
Enrollment
550 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
NCT05382559 Phase 1
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
681 pts
Location
United States, China, France
Sponsor
Astellas Pharma Inc
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of C...
Condition
Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canada, Spain
Sponsor
Cabaletta Bio
NCT07502443 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 2
Enrollment
176 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
NCT07204418 Phase 1
Recruiting
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of ...
Condition
Healthy Volunteers
Enrollment
56 pts
Location
United States
Sponsor
Karuna Therapeutics, Inc., a B
NCT07450547 Phase 2
Recruiting
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
113 pts
Location
United States
Sponsor
Anagram Therapeutics, Inc.
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
304 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT06702449 Phase 1, Phase 2
Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vac...
Condition
Urinary Tract Infections
Enrollment
448 pts
Location
United States, South Africa
Sponsor
GlaxoSmithKline
NCT06479278 N/A
Recruiting
Talk With Me Baby to Enhance the Early Home Language Environment
Condition
Language Development
Enrollment
66 pts
Location
United States
Sponsor
IDeA States Pediatric Clinical
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT03714503 N/A
Recruiting
Head Positioning After Retina Detachment Repair
Condition
Retina; Detachment, Rhegmatogenous
Enrollment
20 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05223803 Phase 2
Recruiting
TERPS Trial for de Novo Oligometastic Prostate Cancer
Condition
Prostate Cancer
Enrollment
122 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology